Investor analysis
The shape of medical venture capital, by the numbers
1,680institutions
1,279companies
1,497investor–company links
12regions
4,888sources
96%quote-backed
By region
United States514
Europe289
Greater China161
Japan105
Southeast Asia94
Canada87
South Korea80
India78
Israel74
Australia & New Zealand72
Taiwan66
Rest of World60
By organization type
Life-science VC firm549
Corporate VC (pharma / medtech / payer / provider / tech)282
Government / public program / sovereign fund142
Incubator / lab space123
Growth equity / late-stage112
University / hospital / research-institute fund110
Accelerator82
Crossover fund (private + public biotech)59
Disease foundation / venture philanthropy50
Family office (health-venture-active)49
Venture studio / company creation (Flagship model)44
Angel network / group36
Micro-VC / emerging manager32
Angel syndicate / SPV9
Equity crowdfunding platform1
By sector
Therapeutics / BioPharma1,027
MedTech / Medical devices694
Digital health676
Diagnostics / Precision testing500
Healthcare services / Care delivery348
Generalist with major health practice346
Life-science tools / Instruments230
Healthcare IT / Infrastructure178
AI drug discovery / TechBio135
Cell & gene therapy105
Pharma services (CRO/CDMO)90
Genomics / Multi-omics72
By modality (top 10)
Biologics / Antibodies (incl. ADC, bispecifics)259
Small molecule257
AI/ML platform234
Medical hardware / Devices233
Software as a medical device (SaMD)230
Cell therapy139
Gene therapy103
Digital therapeutics (DTx)96
Wearables / Biosensors67
Vaccines40
By indication (top 10)
Oncology178
Neurology / CNS92
Infectious disease56
Immunology / Inflammation56
Rare / Genetic disease55
Women's health45
Aging / Longevity37
Cardiovascular36
Metabolic / Obesity / Diabetes33
Psychiatry / Mental health31
By source confidence
High823
Medium766
Low91